Wading into an acrimonious debate over booster doses, researchers in Israel reported on Wednesday that a third dose of the Pfizer-BioNTech coronavirus vaccine can prevent both infections and severe illness in adults older than 60 for at least 12 days. The study, published in the New England Journal of Medicine,Continue Reading

GENEVA — The World Health Organization’s top official in Europe called on Wednesday for urgent action by the authorities and civic groups to control fast-rising cases of monkeypox that he said posed a real risk to public health. Europe has emerged as the epicenter of an outbreak of monkeypox, withContinue Reading

A growing body of preliminary research suggests the Covid vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious Omicron variant. All vaccines still seem to provide a significant degree of protection against serious illness from Omicron, which is the most crucialContinue Reading

Called Mosquirix, the new vaccine is given in three doses between ages 5 and 17 months, and a fourth dose roughly 18 months later. Following the clinical trials, the vaccine was tried out in three countries — Kenya, Malawi and Ghana — where it was incorporated into routine immunization programs.Continue Reading